Mastrapasqua Asset Management’s Novartis NVS Stock Holding History

Mastrapasqua Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$334K	Buy	3,275 +100	+3%	+$10.2K	0.04%	134
2023 Q2	$320K	Sell	3,175 -30	-0.9%	-$3K	0.04%	135
2023 Q1	$295K	Buy	3,205 +820	+34%	+$71.6K	0.04%	141
2022 Q4	$216K	Buy	+2,385	New	+$201K	0.03%	146
2021 Q1	–	Sell	-5,770	Closed	-$545K	–	153
2020 Q4	$545K	Sell	5,770 -63,340	-92%	-$5.53M	0.07%	126
2020 Q3	$6.01M	Buy	69,110 +2,221	+3%	+$192K	0.84%	41
2020 Q2	$5.84M	Buy	66,889 +759	+1%	+$65.5K	0.9%	42
2020 Q1	$5.45M	Buy	66,130 +4,285	+7%	+$382K	1.06%	40
2019 Q4	$5.86M	Buy	61,845 +1,785	+3%	+$160K	0.96%	42
2019 Q3	$5.22M	Buy	60,060 +53,785	+857%	+$4.83M	0.96%	42
2019 Q2	$573K	Buy	6,275 +533	+9%	+$45.1K	0.11%	109
2019 Q1	$495K	Buy	+5,742	New	+$461K	0.09%	114
2016 Q3	–	Sell	-6,199	Closed	-$458K	–	139
2016 Q2	$458K	Sell	6,199 -65,645	-91%	-$4.54M	0.11%	116
2016 Q1	$4.66M	Sell	71,844 -552	-0.8%	-$37.6K	1.09%	36
2015 Q4	$5.58M	Sell	72,396 -1,250	-2%	-$99.3K	1.37%	30
2015 Q3	$6.07M	Buy	73,646 +77	+0.1%	+$6.85K	1.6%	21
2015 Q2	$6.48M	Buy	+73,569	New	+$6.75M	1.57%	23
2015 Q1	–	Sell	-74,629	Closed	-$6.2M	–	91
2014 Q4	$6.2M	Buy	+74,629	New	+$6.19M	1.49%	27
2014 Q2	$6.44M	Buy	79,422 +1,623	+2%	+$128K	1.48%	29
2014 Q1	$5.93M	Sell	77,799 -6,036	-7%	-$440K	1.39%	32
2013 Q4	$6.04M	Buy	83,835 +28	+0%	+$1.95K	1.37%	29
2013 Q3	$5.76M	Buy	83,807 +1,914	+2%	+$127K	1.41%	29
2013 Q2	$5.19M	Buy	+81,893	New	+$5.33M	1.38%	31

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mastrapasqua Asset Management's NVS Position: Q3 2023 in Review

Mastrapasqua Asset Management increased its Novartis (NVS) stake by 3.1% in Q3 2023, buying an estimated $10.2K and bringing the position to 3,275 shares worth $334K. The position accounts for 0.04% of the portfolio, ranked #134.

Mastrapasqua Asset Management first reported a position in NVS in Q2 2013 and has held it in 23 quarters since. The position peaked at $6.48M in Q2 2015. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

Mastrapasqua Asset Management held 3,275 shares of Novartis worth $334K as of Q3 2023.
Mastrapasqua Asset Management bought 100 Novartis shares in Q3 2023, an estimated $10.2K.
Novartis made up 0.04% of Mastrapasqua Asset Management's portfolio in Q3 2023, its #134 holding.
Mastrapasqua Asset Management first reported a position in Novartis in Q2 2013 and has held it in 23 quarters since.
Mastrapasqua Asset Management's Novartis position peaked at $6.48M in Q2 2015.
1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on Mastrapasqua Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.